Shares of Acasti Pharma (NASDAQ:ACST) are jumping more than 25% higher today after a major investment firm initiated coverage. ACST stock has declined by more than 50% year to date (YTD), vastly ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Acasti Pharma (ACST) one of those stocks right now? Let's take a closer look at ...

Penny stock Acasti Pharma (NASDAQ:ACST) is not messing around today. Shares of the pharmaceutical play are up more than 100%! But without any company news, what is behind the move in ACST stock? And ...

Acasti Pharma (NASDAQ:ACST) is a classic example of the extreme volatility of small-cap biotech stocks. It was only in late December that the shares were fetching $2.87, up from $1 a year earlier. But ...

Here is everything potential investors in ACST stock need to know as shares soar higher today. ACST stock was up 44.4% as of Monday morning. On the date of publication, William White did not have ...

Canadian biopharma company Acasti Pharma (NASDAQ:ACST) said on Friday that it will effect a 1-for-6 reverse stock split to increase the company's per share market price and regain compliance with ...

Today, Oppenheimer initiated coverage on ACST stock with an “outperform” rating and a price target of $6. Even after today’s significant price increase, the price target still represents upside of ...